Patents by Inventor Nike T. Beaubier

Nike T. Beaubier has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SYSTEMS AND METHODS FOR DETECTING CELLULAR PATHWAY DYSREGULATION IN CANCER SPECIMENS
    Publication number: 20220351805
    Abstract: Disclosed herein are systems, methods, and compositions useful for determining cellular pathway disruption comprising the use of RNA expression level information. This determined level of disruption can assist in the identification of genetic variants that alter pathway activity, to correlate these variants with disease state and disease progression, and to identify those therapeutics most likely to be effective and which should be avoided.
    Type: Application
    Filed: May 20, 2022
    Publication date: November 3, 2022
    Inventors: Nike T. Beaubier, Joshua SK Bell, Catherine Igartua, Hailey B. Lefkofsky, Lee F. Langer, Joshua Drews
  • Systems and methods for detecting cellular pathway dysregulation in cancer specimens
    Patent number: 11367508
    Abstract: Disclosed herein are systems, methods, and compositions useful for determining cellular pathway disruption comprising the use of RNA expression level information. This determined level of disruption can assist in the identification of genetic variants that alter pathway activity, to correlate these variants with disease state and disease progression, and to identify those therapeutics most likely to be effective and which should be avoided.
    Type: Grant
    Filed: August 14, 2020
    Date of Patent: June 21, 2022
    Assignee: Tempus Labs, Inc.
    Inventors: Nike T. Beaubier, Joshua S K Bell, Catherine Igartua, Hailey B. Lefkofsky, Lee F. Langer, Joshua Drews
  • SYSTEMS AND METHODS FOR DETECTING CELLULAR PATHWAY DYSREGULATION IN CANCER SPECIMENS
    Publication number: 20210057042
    Abstract: Disclosed herein are systems, methods, and compositions useful for determining cellular pathway disruption comprising the use of RNA expression level information. This determined level of disruption can assist in the identification of genetic variants that alter pathway activity, to correlate these variants with disease state and disease progression, and to identify those therapeutics most likely to be effective and which should be avoided.
    Type: Application
    Filed: August 14, 2020
    Publication date: February 25, 2021
    Inventors: Nike T. Beaubier, Joshua SK Bell, Catherine Igartua, Hailey B. Lefkofsky, Lee F. Langer